Egle Therapeutics logo

Egle Therapeutics

Startups icon Seedtable Score 52 Startups icon Startups

1

Founding Rounds

1

Investors

$46.22m

Money raised

Overview

Egle Therapeutics, based in Paris, is developing advanced immunotherapies for cancer and autoimmune diseases. Unlike traditional treatments, which often have severe side effects and limited effectiveness, Egle's approach aims to offer better outcomes with fewer side effects. By targeting immune system mechanisms, Egle can potentially transform patient experiences and increase survival rates. Their B2B model, supported by investors like Bioqube Ventures, positions them to form strategic partnerships and secure resources for growth, making them a promising contender in health tech.
  • Website: https://egle-tx.com
  • Business model: b2b
  • Company size: 11 - 51 employees
  • Headquarters: Paris, France
  • Founded: 2020
  • Social accounts: Linkedin

Investors (1)

Bioqube Ventures logo Bioqube Ventures

Health Tech, Biotech

Details

View all investors.

Join 23,000+ founders, operators and investors.

Fonding

Fonding series

Funding Series Analysis

The company Egle Therapeutics has raised a total of $46.22m in funding over 1 rounds.

Key Insights:

  • Unknown: $46.22m
Egle Therapeutics logo
Egle Therapeutics Unknown (2021, $46M) $46.22m